The Business Research Company
Opdivo nivolumab Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
LONDON, GREATER LONDON, UNITED KINGDOM, January 21, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the Opdivo nivolumab market evolved in recent years?
The Opdivo nivolumab market size has shown significant growth in recent years. The market value rose from $7,709.49 million in 2024 to an estimated $8,335.54 million in 2025, at a compound annual growth rate CAGR of 8.1%. This growth in the historic period can be attributed to the rising prevalence of cancer, increasing expenditure for research and development proficiencies, growing investment in healthcare facilities, an increasing incidence of non-small lung cancer, and consequent growth in healthcare expenditure for capital equipment.
Get Your Free Sample of The Opdivo nivolumab Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=19914&type=smp
What trajectory will Opdivo nivolumab Market take in the future?
Looking ahead, the Opdivo nivolumab market size is expected to experience further robust growth. It is projected to reach $11,281.56 million by 2029 at a CAGR of 7.9%. The forecast period growth can be attributed to a rising acceptance of immunotherapy, enhanced understanding of immunotherapy and its benefits, growth in healthcare expenditure for capital equipment, increasing applications of nivolumab for various indications, and growing preference for immunotherapy treatments. Notable trends in the forecast period include product innovation, expansion into new geographic markets, ongoing clinical trials, a growing trend towards personalized medicine and advancements in cancer research.
Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/opdivo-nivolumab-global-market-report-
What major factors are driving the Opdivo nivolumab market?
Increasing incidence of non-small lung cancer is anticipated to thrust the growth of the Opdivo nivolumab market. Non-small cell lung cancer NSCLC, the most common type of lung cancer, accounts for an overwhelming 85% of all lung cancer cases. The surge in NSCLC incidence can primarily be attributed to factors like smoking, exposure to environmental pollutants, genetic mutations, and a family history of cancer. Opdivo works by blocking the PD-1 receptor on immune cells, thereby augmenting the body's immune response to recognize and eradicate cancer cells.
Who are the major players in the Opdivo nivolumab market?
Prominent companies operating in the Opdivo nivolumab market comprise Bristol-Myers Squibb and Ono Pharmaceutical. Both companies have shown a strong presence and have had significant influence on the market dynamics.
What are the emerging trends in the Opdivo nivolumab market?
A key trend in the Opdivo nivolumab market is the development of combination therapies to enhance the efficacy of treatment and expand its applications across multiple cancer types. These combination approaches aim to overcome resistance mechanisms and provide extensive treatment options for advanced cancer patients.
How is the Opdivo nivolumab market segmented?
The Opdivo nivolumab market can be segmented:
1 By Type: 40 mg/4 mL; 100 mg/10 mL; 240 mg/24 mL
2 By Dosage: Injection; Solution; Other Dosages
3 By Demographic: Adult; Pediatric
4 By Application: Melanoma; Non-small Cell Lung Cancer NSCLC; Malignant Pleural Mesothelioma; Classical Hodgkin Lymphoma CHL; Squamous Cell Carcinoma of the Head and Neck SCCHN; Renal Cell Carcinoma RCC; Other Applications
5 By End-User: Hospitals; Clinics; Other End Users
Which geographical regions are prominent in the Opdivo nivolumab market?
North America was the largest region in the 0pdivo nivolumab market in 2024. Moreover, Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions studied in the Opdivo nivolumab market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse through more similar reports by The Business Research Company:
Protein Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report
Protein Extracts From Single Cell Protein And Other Conventional Sources Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/protein-extracts-from-single-cell-protein-and-other-conventional-sources-global-market-report
Cell Culture Protein Surface Coating Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-culture-protein-surface-coating-global-market-report
About The Business Research Company?
With over 15000+ reports from 27 industries spanning 60+ geographies, The Business Research Company has earned a reputation for providing comprehensive, data-rich research full of insights. With 1,500,000 datasets, in-depth secondary research, and unique insights from industry leaders, you can trust us to provide the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
